What is MindMaze?
Founded in 2012 and headquartered in Switzerland, MindMaze operates at the vanguard of brain technology. The company specializes in the development of medical-grade virtual reality products that leverage advanced computer graphics, brain imaging, and neuroscience to stimulate neural recovery. By creating intuitive human-machine interfaces, MindMaze provides clinicians and patients with sophisticated tools to address complex neurological conditions. Its platform is uniquely positioned to bridge the gap between immersive digital environments and clinical efficacy, establishing the firm as a leader in the burgeoning field of digital neuro-therapeutics.
How much funding has MindMaze raised?
MindMaze has raised a total of $338.5M across 4 funding rounds:
Angel/Seed
$8.5M
Private Equity
$100M
Unspecified
$125M
Other Financing Round
$105M
Angel/Seed (2015): $8.5M, investors not publicly disclosed
Private Equity (2016): $100M led by Hinduja Group
Unspecified (2021): $125M supported by AlbaCore Capital
Other Financing Round (2022): $105M featuring AlbaCore Capital, Hambro Perks, and Concord Health Partners
Key Investors in MindMaze
Hinduja Group
The Hinduja Group is a diversified and transnational conglomerate company. Their investments span across industries including automotive, oil, banking, power, media, healthcare and more.
AlbaCore Capital
AlbaCore Capital Group is a prominent European credit manager specializing in private credit and special situations investments, focusing on providing private capital solutions and direct lending.
Hambro Perks
Hambro Perks is a London-headquartered international investment firm focused on private technology investing, partnering with founders to support growth businesses across all stages.
What's next for MindMaze?
With the recent influx of $105M, MindMaze is well-positioned to transition into a phase of rapid commercial expansion and product diversification. The strategic focus will likely center on scaling its clinical footprint across international markets and refining its human-machine interface technology for broader therapeutic applications. As the company moves beyond its initial development phase, the integration of its VR-based recovery tools into standard hospital workflows will be a key performance indicator. Furthermore, the continued support from institutional investors suggests a long-term commitment to building a sustainable, high-growth enterprise that defines the future of neuro-rehabilitation and digital health infrastructure.
See full MindMaze company page
